CLASS II ONGOING Device recall · Reported 4 Sep 2024 · FDA Enforcement Report

Cardiovit recalled by Schiller, Ag

Schiller is recalling Cardiovit At-180, distributed in Florida. The recall was initiated on 24 Jul 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 07613365002775. All serial numbers, all software versions.
Quantity recalled1084 untis

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2734-2024
FDA event ID
95074
Recalling firm
Schiller, Baar
Classification
Class II
Status
Ongoing
Recall initiated
24 Jul 2024
FDA classified
27 Aug 2024
Reported
4 Sep 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

24 Jul 2024Recall initiated by company
27 Aug 2024Classified by FDA+34 days
4 Sep 2024Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for high-frequency signal artifacts is recorded during an ECG acquisition performed by CARDIOVIT AT-180 electrocardiographs.

Product as listed by the FDA

CARDIOVIT AT-180. Model Number: 0A.110000; Catalog number: 3.920570

Where it was distributed

Worldwide - US distribution in the state of Florida and the countries of Austria, Belgium, Switzerland, Cyprus, Czechia, Germany, Spain, Finland, France, Great Britain, Ireland, Iceland, Italy, Luxembourg, Malta, The Netherlands, Norway, Portugal, Romania, Sweden, Slovenia, Australia, The United Arab Emirates, Bahrain, Canada, China, Israel, India, Jordan, Kuwait, Libya, Morocco, Malaysia, Qatar, Serbia, South Africa.

Florida

Questions about this recall

Why was it recalled?

Potential for high-frequency signal artifacts is recorded during an ECG acquisition performed by CARDIOVIT AT-180 electrocardiographs.

Which lots are affected?

UDI-DI: 07613365002775. All serial numbers, all software versions.

Where was it sold?

Worldwide - US distribution in the state of Florida and the countries of Austria, Belgium, Switzerland, Cyprus, Czechia, Germany, Spain, Finland, France, Great Britain, Ireland, Iceland, Italy, Luxembourg, Malta, The Netherlands, Norway, Portugal, Romania, Sweden, Slovenia, Australia, The United Arab Emirates, Bahrain, Canada, China, Israel, India, Jordan, Kuwait, Libya, Morocco, Malaysia, Qatar, Serbia, South Africa.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Schiller

All 2
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIArgus PB-3000, Reference Numbers: 1A.701307 recalled by Schiller, AgSchillerOtherNationwide

Other Other Medical Devices recalls

All 13,929